Fiche centre
Mayo Clinic
Phoenix — United States
Essais liés4clinical trials
VillePhoenixlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06285643
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| AAV2-GDNF gene therapy | Parkinson | Phase 2 | NCT06285643 | A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) | ACTIVE_NOT_RECRUITING |
| ALLO-329 | Lupus | Phase 1 | NCT07085104 | RESOLUTION — A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease | RECRUITING |
| RLB — Determining the Utility of a Behavioral Intervention in Chronic Migraine | Migraine | Non applicable | NCT05415020 | RLB — Determining the Utility of a Behavioral Intervention in Chronic Migraine | RECRUITING |
| SMARTMig — Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial | Migraine | Non applicable | NCT06170281 | SMARTMig — Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial | NOT_YET_RECRUITING |